Davido, David J <br/><br/>
The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.  [electronic resource] 

 -  Journal of virology  Feb 2002 
 - 1077-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-538X 
<br/><br/><label>Standard No.: </label>10.1128/jvi.76.3.1077-1088.2002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Nucleus--metabolism<br/>Chlorocebus aethiops<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Electrophoresis, Polyacrylamide Gel<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression<br/>Genetic Engineering<br/>Herpesvirus 1, Human--drug effects<br/>Humans<br/>Immediate-Early Proteins--drug effects<br/>Peptide Mapping<br/>Phosphoproteins--analysis<br/>Phosphorylation--drug effects<br/>Promoter Regions, Genetic<br/>Protein Processing, Post-Translational--drug effects<br/>Purines--pharmacology<br/>Roscovitine<br/>Trans-Activators--drug effects<br/>Transcriptional Activation--drug effects<br/>Trypsin<br/>Ubiquitin-Protein Ligases<br/>Vero Cells<br/>Viral Proteins--genetics<br/>beta-Galactosidase--genetics